Ancora Advisors LLC - CAPSTONE THERAPEUTICS CORPORAT ownership

CAPSTONE THERAPEUTICS CORPORAT's ticker is CAPSD and the CUSIP is 14068E208. A total of 1 filers reported holding CAPSTONE THERAPEUTICS CORPORAT in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Ancora Advisors LLC ownership history of CAPSTONE THERAPEUTICS CORPORAT
ValueSharesWeighting
Q3 2023$13,3950.0%1,7860.0%0.00%
Q2 2023$13,395
-62.5%
1,7860.0%0.00%
-100.0%
Q1 2023$35,720
+101957.1%
1,7860.0%0.00%0.0%
Q4 2022$35
-99.9%
1,7860.0%0.00%
-50.0%
Q3 2022$66,0000.0%1,7860.0%0.00%0.0%
Q2 2022$66,000
+3.1%
1,7860.0%0.00%0.0%
Q2 2021$64,000
+1.6%
1,7860.0%0.00%0.0%
Q1 2021$63,000
-8.7%
1,7860.0%0.00%0.0%
Q4 2020$69,000
+155.6%
1,7860.0%0.00%
+100.0%
Q3 2020$27,000
-6.9%
1,7860.0%0.00%0.0%
Q2 2020$29,000
+7.4%
1,7860.0%0.00%0.0%
Q4 2019$27,0001,7860.00%
Other shareholders
CAPSTONE THERAPEUTICS CORPORAT shareholders Q4 2019
NameSharesValueWeighting ↓
Ancora Advisors LLC 1,786$27,0000.00%
View complete list of CAPSTONE THERAPEUTICS CORPORAT shareholders